Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.
Mariana T. Mendez
Tapojyoti Sanyal
Murali K. Mamidi
Stacey M. Fernandes
S. Vesely
Marek Mraz
Jennifer R. Brown
J. Holter-Chakrabarty
Asish K. Ghosh
Medicine